|
|
- 2015
肾细胞癌免疫治疗的研究进展DOI: 10.3971/j.issn.1000-8578.2015.09.015 Keywords: New Target of Immunotherapy for Esophageal Cancer,Anti-glioma Effect of Dendritic Cells Modified by RPL8 Gene,Effect of Interfering Tumor Microenvironment on Homing and Killing Activity of Cytotoxic T Lymphocytes,Clinical Analysis of Patients Suffering from Advanced Malignancy with Survival Time Less Than 3 Months by DC-CIK Cells,Cancer-testis Antigen Expression in Breast Cancer,Proliferative Role of Notch1 Signaling in Renal Cell Carcinoma,恶性黑色素瘤内科治疗研究进展,Immunoprophylaxis Mechanism of Mustard Seed against Colorectal Cancer in Rats#br# Induced by 1,2-Dimethylhydrazine Abstract: 摘要 肾细胞癌（renal cell carcinoma, RCC）是成年男性常见的恶性肿瘤, 其发病率和死亡率排名均较前。免疫治疗能够激活机体免疫系统产生对肿瘤的反应使疾病稳定，但高剂量不良反应限制了其在临床的广泛应用。而靶向药物的兴起让肾癌患者治疗方式向靶向治疗转变。随着对肾癌临床治疗方式的不断深入研究，发现单纯的免疫或靶向治疗难以得到令人满意的疗效。因此有学者提出肾细胞癌的治疗应该向免疫联合靶向治疗方向转变。本文旨在对当前肾细胞癌相关免疫治疗的临床研究作一综述，以期为临床肾细胞癌的免疫治疗提供一定的理论依据
|
